Aspoxicillin (trade name Doyle[1]) is an antibiotic drug of the beta-lactam class.[2] It is an injectable form of penicillin that is highly active against Gram-positive and Gram-negative bacteria, including Bacillus fragilis,[3] which is resistant to other beta-lactam antibiotics.[4] It is approved for use in Japan.[1]

Aspoxicillin
Clinical data
Trade namesDoyle
Other namesTA-058
Identifiers
  • (2S,5R,6R)-6-[[(2R)-2-[[(2R)-2-Amino-4-(methylamino)-4-oxobutanoyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
CAS Number
PubChem CID
DrugBank
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.162.655 Edit this at Wikidata
Chemical and physical data
FormulaC21H27N5O7S
Molar mass493.54 g·mol−1

References

edit
  1. ^ a b "Aspoxicillin". IUPHAR/BPS Guide to Pharmacology.
  2. ^ Matsumoto K (July 1987). "[Review: New antimicrobial agent series XXII: Aspoxicillin]". The Japanese Journal of Antibiotics. 40 (7): 1221–1242. PMID 3316732.
  3. ^ "Aspoxicillin". Inxight Drugs. National Center for Advancing Translational Sciences.
  4. ^ Edwards R (December 1997). "Resistance to beta-lactam antibiotics in Bacteroides spp". Journal of Medical Microbiology. 46 (12): 979–986. doi:10.1099/00222615-46-12-979. PMID 9402919.